Balkau B, Papoz L
Clinical and Epidemiological Research Unit, INSERM U21, Villejuif, France.
J Epidemiol Community Health. 1992 Feb;46(1):63-5. doi: 10.1136/jech.46.1.63.
The aim was to assess the level of mortality related to diabetes in France. In other countries, an underrecording of diabetes on the death certificates of diabetic patients has been reported.
Estimated death rate of diabetic patients was calculated using (a) the actual number of death certificates where diabetes was registered either as an underlying or as a contributory cause of death, and (b) estimates of the prevalence of diabetes in the population, by sex and age group, from which expected numbers of diabetic deaths were determined. Standardised mortality ratios were calculated using 1988 French mortality statistics as reference.
The estimated standardised mortality ratio for diabetic subjects, with diabetes registered as the underlying cause, was 0.36. This standardised mortality ratio increased to 0.92 if both the underlying and contributory causes were considered. The estimated death rate, by sex and age group, implies that diabetes has a protective effect between the ages of 45 and 64 years, particularly in men.
Evidence suggests that diabetes is completely omitted on the death certificates of many diabetic subjects, especially for those between the ages of 45 and 64 years. Using mortality statistics underestimates the prevalence of diabetes and its effects on public health. The difference in diabetes mortality between countries will not be reliable until there is a better registration of the causes of death in diabetic patients, and contributory as well as the underlying cause are coded and published.
旨在评估法国糖尿病相关的死亡率水平。在其他国家,已有报道称糖尿病患者死亡证明上糖尿病记录不足。
糖尿病患者的估计死亡率通过以下方式计算:(a) 将糖尿病登记为根本死因或促成死因的死亡证明实际数量,以及(b) 根据按性别和年龄组划分的人群中糖尿病患病率估计值来确定糖尿病死亡的预期数量。使用1988年法国死亡率统计数据作为参考计算标准化死亡率。
将糖尿病登记为根本死因的糖尿病患者估计标准化死亡率为0.36。如果同时考虑根本死因和促成死因,该标准化死亡率升至0.92。按性别和年龄组划分的估计死亡率表明,糖尿病在45至64岁之间具有保护作用,尤其是在男性中。
有证据表明,许多糖尿病患者的死亡证明上完全遗漏了糖尿病,特别是对于45至64岁之间的患者。使用死亡率统计数据会低估糖尿病患病率及其对公共卫生的影响。在糖尿病患者的死因有更好的登记,且促成死因和根本死因都进行编码并公布之前,各国之间糖尿病死亡率的差异将不可靠。